Healthcare - Biotechnology - NASDAQ - US
$ 3.54
-3.8 %
$ 8.88 M
Market Cap
-0.55
P/E
INCOME STATEMENT
839 K
REVENUE
-7.7 M
OPERATING INCOME
-6.14 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Soligenix, Inc.
| Revenue | 839 K |
| Cost Of Revenue | 742 K |
| Gross Profit | 97.3 K |
| Operating Expenses | 7.8 M |
| Operating Income | -7.7 M |
| Other Expenses | -1.56 M |
| Net Income | -6.14 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | Dec-1997 | Jan-1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||||
| Revenue | 0.8 | 0.9 | 0.8 | 2.4 | 4.6 | 5.2 | 5.4 | 10.4 | 8.8 | 7.0 | 3.2 | 3.1 | 7.7 | 1.9 | 2.8 | 2.3 | 1.3 | 2.3 | 3.1 | 1.0 | 83.8 K | 0 | 0 | 0 | 1 | 0.2 | 100 K | 0 |
| GROSS PROFIT | ||||||||||||||||||||||||||||
| Cost Of Revenue | 0.7 | 0.6 | 0.7 | 1.8 | 3.6 | 4.6 | 4.3 | 8.4 | 6.9 | 5.3 | 2.5 | 2.6 | 2.1 | 1.6 | 1.5 | 1.9 | 0.9 | 2.0 | 2.1 | 0.9 | 76.2 K | 0 | 0 | 0 | (1.4) | (1.7) | (0.5) | 0 |
| Gross Profit | 97.3 K | 0.4 | 95.6 K | 0.5 | 1.1 | 0.6 | 1.1 | 2.0 | 1.9 | 1.7 | 0.7 | 0.6 | 5.6 | 0.3 | 1.3 | 0.4 | 0.3 | 0.3 | 1.0 | 60.8 K | 7.62 K | 0 | 0 | 0 | 1.4 | 1.9 | 0.6 | 0 |
| OPERATING INCOME | ||||||||||||||||||||||||||||
| Operating Expenses | 7.8 | 14.5 | 13.1 | 19.0 | 11.2 | 9.7 | 8.7 | 7.7 | 9.0 | 8.5 | 7.8 | 5.2 | 8.5 | 8.2 | 7.4 | 3.9 | 6.6 | 8.5 | 5.8 | 6.0 | 5.2 | 5.9 | 14.6 | 3.1 | 6.5 | 8.3 | 3.8 | 1.3 |
| Selling, General and Administrative Expenses | 4.5 | 6.7 | 4.8 | 4.0 | 3.5 | 3.0 | 3.2 | 3.4 | 3.6 | 3.4 | 2.8 | 2.6 | 2.2 | 2.5 | 2.9 | 2.1 | 3.5 | 3.1 | 2.2 | 2.3 | 2.5 | 3.0 | 2.0 | 2.1 | 3.0 | 3.5 | 1.5 | 0.3 |
| Research and Development Expenses | 3.3 | 7.9 | 8.4 | 15.1 | 8.1 | 6.8 | 5.5 | 4.3 | 5.4 | 5.1 | 5.1 | 2.6 | 6.3 | 5.7 | 4.5 | 1.7 | 3.1 | 4.6 | 3.7 | 3.7 | 2.7 | 2.9 | 2.5 | 1.0 | 2.0 | 3.1 | 1.8 | 0.9 |
| Operating Income | (7.7) | (14.1) | (13.0) | (18.5) | (10.1) | (9.1) | (7.6) | (5.7) | (7.1) | (10.8) | (7.2) | (4.7) | (3.0) | (7.9) | (6.1) | (3.5) | (6.3) | (8.2) | (4.8) | (5.9) | (5.2) | (5.9) | (14.6) | (3.1) | (5.1) | (6.4) | (3.2) | (1.3) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||||
| Interest Income Expense | 49.1 K | 0.8 | 0.9 | 10.9 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 742 | 2.68 K | 3.28 K | 0 | 0 | 0 | 0 | 0 | 35.8 K | 35.8 K | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (0.2) | (0.7) | (0.4) | 61.1 K | 0.6 | 0.2 | 29.9 K | 1.9 | (1.2) | 3.4 | (3.7) | 6.2 K | 7.44 K | 0.2 | 16.8 K | 33.8 K | 0.2 | 36.2 K | 0.1 | 45.5 K | 61.6 K | 5.92 K | 5.92 K | (2.4) | (2.9) | (15.2) | 0.2 | 74.8 K |
| Pre-Tax Income | (7.9) | (15.0) | (13.4) | (18.5) | (10.0) | (8.9) | (7.6) | (3.8) | (8.3) | (7.3) | (10.8) | (4.7) | (3.0) | (7.6) | (6.1) | 0 | (6.3) | (9.0) | 0 | (5.9) | (5.3) | (14.6) | (14.6) | (5.5) | (7.9) | (21.6) | (3.0) | (1.2) |
| NET INCOME | ||||||||||||||||||||||||||||
| Tax Provision | (1.8) | (1.2) | (0.9) | (0.8) | (0.6) | 0.2 | (0.4) | (0.5) | (0.5) | (0.6) | (0.8) | (0.5) | (0.6) | (0.2) | 16.8 K | 33.8 K | (0.2) | 36.2 K | (0.1) | 45.5 K | 61.6 K | (1.0) | 5.92 K | 1.7 | 2.4 | 15.4 | 0 | 0 |
| Net Income | (6.1) | (13.8) | (12.6) | (17.7) | (9.4) | (8.9) | (7.1) | (3.2) | (7.8) | (6.7) | (10.1) | (4.2) | (2.4) | (7.4) | (6.0) | (3.4) | (6.2) | (8.2) | (4.7) | (5.9) | (5.3) | (5.0) | (14.6) | (4.8) | (7.5) | (21.8) | (3.2) | (1.2) |
| EPS | 12.7 | 77 | 75.1 | 154 | 116 | 162 | 279 | 224 | 721 | 0 | 0 | 56.1 | 32.6 | 109 | 108 | 101 | 204 | 384 | 285 | 434 | 544 | 662 | 3.26 K | 1.18 K | 2.09 K | 6.57 K | 3.06 K | 703 |